Jarno Salonen focuses on Drug delivery, Porous silicon, Nanotechnology, Nanoparticle and Silicon. His study in Drug delivery is interdisciplinary in nature, drawing from both Biodistribution, Bioavailability, Active ingredient, Pharmacology and Mucoadhesion. His work deals with themes such as Inorganic chemistry, Carbonization, Acetylene and Thermal oxidation, which intersect with Porous silicon.
Jarno Salonen has researched Nanotechnology in several fields, including Biocompatibility and Biological activity. His Nanoparticle research includes elements of Microfluidics, Biophysics, Controlled release, Polymer and Cytotoxicity. As a part of the same scientific family, Jarno Salonen mostly works in the field of Silicon, focusing on Analytical chemistry and, on occasion, Fourier transform infrared spectroscopy, Activated carbon and Hydrosilylation.
Jarno Salonen mainly investigates Porous silicon, Nanotechnology, Drug delivery, Nanoparticle and Silicon. His Porous silicon study combines topics in areas such as Acetylene, Carbonization, Surface modification and Analytical chemistry. He focuses mostly in the field of Nanotechnology, narrowing it down to matters related to Cancer cell and, in some cases, Membrane.
His research in Drug delivery intersects with topics in Biocompatibility, Drug and Biomedical engineering. His Nanoparticle study incorporates themes from In vitro, Biodistribution, Nanocomposite, Biophysics and Polymer. Jarno Salonen usually deals with Silicon and limits it to topics linked to Mesoporous material and Microparticle, Dissolution and Adsorption.
His main research concerns Nanoparticle, Porous silicon, Drug delivery, Nanotechnology and Biophysics. His Nanoparticle research focuses on Biomaterial and how it connects with Adsorption and Porosity. Silicon covers he research in Porous silicon.
His work carried out in the field of Silicon brings together such families of science as Etching and Mesoporous material. The concepts of his Drug delivery study are interwoven with issues in Drug, Biocompatibility, Cell membrane, Mesenchymal stem cell and Biomedical engineering. Jarno Salonen works mostly in the field of Nanotechnology, limiting it down to concerns involving Dextran and, occasionally, Liver failure, Liver regeneration and Nanocomposite.
His primary areas of investigation include Drug delivery, Nanotechnology, Nanoparticle, Drug and Porous silicon. The study incorporates disciplines such as Bone regeneration, Composite number, Erythrocyte membrane and Gelatin in addition to Drug delivery. His study in Nanotechnology is interdisciplinary in nature, drawing from both pH-sensitive polymers, Dextran and Fc receptor.
His Nanoparticle study combines topics from a wide range of disciplines, such as Chitosan, Rheumatoid arthritis, Distribution and Cell membrane. His Drug study integrates concerns from other disciplines, such as Colloidal gold, In vitro model, Gastrointestinal tract and Nanocomposite. His Porous silicon research is multidisciplinary, incorporating perspectives in Characterization, Optical sensing, Carbonization and Surface modification.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs.
J. Salonen;L. Laitinen;A.M. Kaukonen;J. Tuura.
Journal of Controlled Release (2005)
Mesoporous silicon in drug delivery applications.
Jarno Salonen;Ann M. Kaukonen;Jouni Hirvonen;Vesa-Pekka Lehto.
Journal of Pharmaceutical Sciences (2008)
Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats
Luis M. Bimbo;Mirkka Sarparanta;Hélder A. Santos;Anu J. Airaksinen.
ACS Nano (2010)
Use of thermoanalytical methods in quantification of drug load in mesoporous silicon microparticles
V.-P. Lehto;K. Vähä-Heikkilä;J. Paski;J. Salonen.
Journal of Thermal Analysis and Calorimetry (2005)
Mesoporous silica material TUD-1 as a drug delivery system.
T. Heikkilä;J. Salonen;J. Tuura;M.S. Hamdy.
International Journal of Pharmaceutics (2007)
Evaluation of Mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 Materials as API Carriers for Oral Drug Delivery
T. Heikkilä;J. Salonen;J. Tuura;N. Kumar.
Drug Delivery (2007)
Fabrication and chemical surface modification of mesoporous silicon for biomedical applications
Jarno Salonen;Vesa-Pekka Lehto.
Chemical Engineering Journal (2008)
In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size.
Hélder A. Santos;Joakim Riikonen;Jarno Salonen;Ermei Mäkilä.
Acta Biomaterialia (2010)
Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices.
Natalja Genina;Jenny Holländer;Harri Jukarainen;Ermei Mäkilä.
European Journal of Pharmaceutical Sciences (2016)
Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
Luis M. Bimbo;Ermei Mäkilä;Timo Laaksonen;Vesa-Pekka Lehto.
Biomaterials (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Turku
University of Helsinki
University of Helsinki
Åbo Akademi University
Åbo Akademi University
Åbo Akademi University
University of Helsinki
University of Helsinki
Commonwealth Scientific and Industrial Research Organisation
King Saud University
University of Washington
Ludwig-Maximilians-Universität München
Tsinghua University
Hong Kong Baptist University
University of Canterbury
Sorbonne University
University of California, Davis
University of Pennsylvania
National Institutes of Health
Utrecht University
Delft University of Technology
Technical University of Munich
University of Pittsburgh
New York University
University of Liverpool
University of Utah